<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03519659</url>
  </required_header>
  <id_info>
    <org_study_id>RP0308/2014H0437</org_study_id>
    <secondary_id>R01CA195513</secondary_id>
    <nct_id>NCT03519659</nct_id>
  </id_info>
  <brief_title>Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT</brief_title>
  <official_title>Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio Third Frontier</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess new low radiation dose techniques for clinical PET/CT
      scans through intra-individual comparison between a clinical, standard dose scan and a
      low-dose scan, completed within one week of each other.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Positron Emission Tomography/Computed Tomography (PET/CT) imaging using 18F-FDG is an
      important, commonly used cancer, neuroscience and cardio-vascular imaging methodology to
      detect disease and to monitor therapeutic interventions. While considerable technological
      progress of PET/CT systems has occurred over the last decade, we have not re-evaluated the
      ability to potentially reduce the radiation burden of the used PET imaging pharmaceutical
      (FDG).

      This early phase trial intends to accomplish the following:

        -  to validate that the radiation dose burden from the PET imaging pharmaceutical (FDG) can
           be reduced by more than 50% from the current standard of clinical care (SOC) level
           without affecting the diagnostic ability;

        -  to confirm that a low dose approach will be feasible for response assessment;

        -  to validate that the difference in FDG uptake between imaging 60 min +/- 10 min post
           injection and 75 min +/- 10 min post injection is independent/equivalent of the injected
           FDG dose

        -  to validate a simulation methodology to streamline future dose finding studies for PET
           imaging pharmaceuticals.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 21, 2015</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality</measure>
    <time_frame>through study completion, on average 2-5 years</time_frame>
    <description>assessed by blinded readers</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Artifacts</measure>
    <time_frame>through study completion, on average 2-5 years</time_frame>
    <description>assessed by blinded readers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lesion detectability</measure>
    <time_frame>through study completion, on average 2-5 years</time_frame>
    <description>assessed by blinded readers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image noise</measure>
    <time_frame>through study completion, on average 2-5 years</time_frame>
    <description>assessed by blinded readers</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">204</enrollment>
  <condition>PET/CT Imaging</condition>
  <arm_group>
    <arm_group_label>Sub-Study A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive PET/CT scan on Gemini Astonish PET/CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sub-Study B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive PET/CT scan on Biograph mCT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sub-Study C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive PET/CT scan on Discovery PET/CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sub-Study D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive PET/CT scan on Vereos 128 digital PET/CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sub-Study E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive lower radiation dose on Vereos 128 digital PET/CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sub-Study F</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive PET/SCAN using system that did not show equivalence in Sub-Study A-C</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PET/CT scan with 13 mCi radiation dose</intervention_name>
    <description>13 mCi 18F-FDG dose</description>
    <arm_group_label>Sub-Study A</arm_group_label>
    <arm_group_label>Sub-Study B</arm_group_label>
    <arm_group_label>Sub-Study C</arm_group_label>
    <arm_group_label>Sub-Study D</arm_group_label>
    <arm_group_label>Sub-Study F</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PET/CT scan with 5 mCi radiation dose</intervention_name>
    <description>5 mCi 18F-FDG dose</description>
    <arm_group_label>Sub-Study A</arm_group_label>
    <arm_group_label>Sub-Study B</arm_group_label>
    <arm_group_label>Sub-Study C</arm_group_label>
    <arm_group_label>Sub-Study D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PET/CT scan with 2.5 mCi radiation dose</intervention_name>
    <description>2.5 mCi 18F-FDG dose</description>
    <arm_group_label>Sub-Study E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PET/CT Scan with 6.5 mCi radiation dose</intervention_name>
    <description>6.5 mCi 18F-FDG dose</description>
    <arm_group_label>Sub-Study E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PET/CT Scan with not yet determined radiation dose</intervention_name>
    <description>We plan for the possibility that one of the three-Sub-Studies (A-B) would not demonstrate equivalency, and we would then perform a modified protocol in which the SOC dosing is compared to a lower and higher dose than originally tested.</description>
    <arm_group_label>Sub-Study F</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female patients greater than or equal to 18 years of age

          -  Patients scheduled for a standard of care PET/CT scan

          -  For female patients of child-bearing potential, the OSUWMC requirements for receiving
             the standard of care PET imaging agent and CT examination needs to be met

        Exclusion Criteria:

          -  Participants who are pregnant or lactating

          -  Prisoners

          -  Participants incapable of giving informed consent

          -  Patients unable to lie flat on the scanner for extended periods of time
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael V Knopp, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melanie Hughes</last_name>
    <phone>614-293-9998</phone>
    <email>office@wcibmi.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael V Knopp, MD, PhD</last_name>
    <phone>614-293-9998</phone>
    <email>knopp.16@osu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael V Knopp, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Chadwick L Wright, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jun Zhang, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>May 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2018</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Michael V. Knopp MD, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

